Lakewood-Amedex Biotherapeutics

Micro-cap biotech Lakewood-Amedex Biotherapeutics files for a Nasdaq direct listing IPO Overview Lakewood-Amedex Biotherapeutics, which is developing a topical antimicrobial treatment for drug-resistant infections, filed on Friday for a direct listing on the Nasdaq. The shares of common stock listed... Read more